What's new? Log in Free sign up

Accelerate Diagnostics (AXDX) News and press releases

Company Profile

News

From Benzinga Pro

Recap: Accelerate Diagnostics Q1 Earnings

Accelerate Diagnostics Q1 EPS $(0.17) Misses $(0.14) Estimate, Sales $2.81M Miss $3.35M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.17) per share which missed the analyst consensus estimate of $(0.14) by 21.43 percent. This is a 32 percent increase over losses of $(0.25) per share

Earnings Scheduled For May 11, 2023

Companies Reporting Before The Bell • Takeda Pharmaceutical (NYSE:TAK) is likely to report earnings for its fourth quarter. • Exela Technologies (NASDAQ:XELA) is expected to report earnings for its first quarter.

Why Guardforce AI Shares Are Trading Lower By 59%; Here Are 20 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Aptorum Group Limited (NASDAQ: APM) gained 164.3% to $7.40 in pre-market trading after gaining 8% on Tuesday. Aptorum Group recently reported 2022 fiscal year-end financial results and issued business update.

Top 5 Health Care Stocks That May Collapse

News, Penny Stocks, Short Ideas, Pre-Market Outlook, Markets, Trading Ideas

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Dow Rises 100 Points; Accelerate Diagnostics Shares Spike Higher

Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining around 100 points on Thursday. The Dow traded up 0.31% to 32,819.16 while the NASDAQ rose 0.63% to 12,001.83. The S&P 500, also rose, gaining, 0.46% to 4,046.40.

12 Health Care Stocks Moving In Thursday's Intraday Session

Why Bed Bath & Beyond Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas

Gainers SCYNEXIS, Inc. (NASDAQ: SCYX) shares climbed 68% to $2.8184 after the company announced an exclusive license agreement with GSK for Brexafemme, in which the company will receive an upfront payment of $90 million.

Accelerate Diagnostics Q4 EPS $(0.15), Inline, Sales $2.97M Beat $2.87M Estimate

Accelerate Diagnostics (NASDAQ:AXDX) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 34.78 percent increase over losses of $(0.23) per share from the same period last

Earnings Scheduled For March 29, 2023

Companies Reporting Before The Bell • NeoGenomics (NASDAQ:NEO) is estimated to report quarterly earnings at $0.16 per share on revenue of $195.54 million.

Earnings Preview For Accelerate Diagnostics

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Why FreightCar America Shares Are Trading Lower By 8%; Here Are 20 Stocks Moving Premarket

News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas

Gainers Biodexa Pharmaceuticals (NASDAQ: BDRX) shares rose 76% to $0.8276 in pre-market trading after gaining 65% on Monday.

Reported Late Tuesday March 14, Accelerate Diagnostics Announces Departure Of CFOSteve Reichling And Appointment Of David Patience As Replacement Effective April 1, 2023

News, Management

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief Financial Officer (CFO),

Press releases

From Benzinga Pro

Accelerate Diagnostics Reports First Quarter 2023 Financial Results

Earnings, Press Releases

TUCSON, Ariz., May 11, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced financial results for the first quarter for the period ended March 31, 2023.

Accelerate Diagnostics scheduled call to review 2023 first quarter results

TUCSON, Ariz., April 27, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) announced today that management will host a conference call on Thursday, May 11, 2023, at 4:30 p.m. Eastern Time to review 2023

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Earnings, Press Releases

TUCSON, Ariz., March 29, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022.

Accelerate Diagnostics scheduled call to review 2022 fourth quarter and full year results

TUCSON, Ariz., March 15, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) announced today that management will host a conference call on Wednesday, March 29, 2023, at 4:30 p.m. Eastern Time to review 2022

Accelerate Diagnostics announces departure of CFO Steve Reichling and appointment of David Patience as replacement

Small Cap, Press Releases

TUCSON, Ariz., March 14, 2023 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) a leading provider of innovative rapid diagnostic solutions, announced today that Steve Reichling will be stepping down as Chief

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.